Intellia股价因FDA优先审评而上涨 (NTLA:NASDAQ)
· seekingalpha.com
Intellia Therapeutics (NTLA)股价因lonvo-z（一种针对遗传性血管性水肿的基因编辑疗法）获得FDA优先审评而上涨。在此阅读更多信息。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...